BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 15367860)

  • 1. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC
    Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
    Dalakas MC
    Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyositis and dermatomyositis.
    Dalakas MC; Hohlfeld R
    Lancet; 2003 Sep; 362(9388):971-82. PubMed ID: 14511932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
    Schmidt J; Rakocevic G; Raju R; Dalakas MC
    Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: An update on inflammatory and autoimmune myopathies.
    Dalakas MC
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):226-42. PubMed ID: 21155862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of inflammatory and autoimmune myopathies.
    Dalakas MC
    Presse Med; 2011 Apr; 40(4 Pt 2):e237-47. PubMed ID: 21411269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis of primary inflammatory myopathies].
    Benveniste O; Squier W; Boyer O; Hilton-Jones D; Herson S
    Presse Med; 2004 Nov; 33(20):1444-50. PubMed ID: 15611679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects.
    Dalakas MC
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):948-58. PubMed ID: 12407303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory, immune, and viral aspects of inclusion-body myositis.
    Dalakas MC
    Neurology; 2006 Jan; 66(2 Suppl 1):S33-8. PubMed ID: 16432143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular immunology and genetics of inflammatory muscle diseases.
    Dalakas MC
    Arch Neurol; 1998 Dec; 55(12):1509-12. PubMed ID: 9865793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic inflammatory myopathies.
    Amato AA; Barohn RJ
    Neurol Clin; 1997 Aug; 15(3):615-48. PubMed ID: 9227956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cells in muscle in inclusion body myositis and polymyositis.
    Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
    Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Three patients with divergent presentations of idiopathic inflammatory myopathy].
    Bronner IM; van der Meulen MF; Linssen WH; Hoogendijk JE; de Visser M
    Ned Tijdschr Geneeskd; 2002 May; 146(18):833-8. PubMed ID: 12038218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of myositis: issues, concerns and future prospects.
    Dalakas MC
    Nat Rev Rheumatol; 2010 Mar; 6(3):129-37. PubMed ID: 20125096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
    Dalakas MC
    J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic targets for idiopathic inflammatory myopathies.
    De Bleecker JL; Creus KK; De Paepe B
    Drug News Perspect; 2006 Nov; 19(9):549-57. PubMed ID: 17220960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.